Comparison of Standard of Care or Treatment on Protocol

Lung Cancer Clinical Trial

Official title: Randomized Study of Patients (Patient Choice) Who Are Not Eligible for Variations of Standard of Care Protocols When Treated Either on Best Standard of Care Pathways or Per a Protocol Arm That They Failed to Enroll to

Status Terminated

Clinical Trial Summary

Patient will choose to either receive the standard of care according to National Comprehensive Cancer Network (NCCN) or approved guidelines for their condition or to be treated according to one arm of the protocol that they could not be enrolled on. The selection of the arm will be at physician discretion.

Clinical Trial Description

All patients failing to enroll in a specific therapeutic research protocol using FDA approved drugs or CTMS accepted therapies will be screened for this study. Patients will be randomized (Patient own choice) to either standard of care described in the NCCN guidelines and published as peer-reviewed phase II or III studies which show an efficacy or to one of the arms of the protocol they fail to enroll in, as determined by the treating physician. ;

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Bladder Cancer
• Esophageal Cancer
• Esophageal Neoplasms
• Lung Cancer
• Ovarian Cancer
• Skin Cancer
• Stomach Cancer
• Stomach Neoplasms
• Uterine Cancer
• Uterine Neoplasms

• NCT number: NCT01010334
• Study type: Interventional
• Source: New Mexico Cancer Care Alliance
• Status: Terminated
• Phase: N/A
• Start date: March 2009
• Completion date: July 2011